?:definition
|
-
An immunotherapy regimen consisting of pembrolizumab that may be used in the treatment of anal carcinoma; bladder, gastric, bone, colorectal, cervical, lung, penile, testicular, prostate, hepatobiliary, endometrial, and vulvar cancers; chronic lymphocytic leukemia (CLL); small lymphocytic lymphoma (SLL); diffuse large B-cell lymphoma (DLBCL); and cutaneous melanoma.
|